-
Pakistan Accelerates Local Vaccine Production to Boost Health Security
Pakistan’s Push for Local Vaccine Production Gains Momentum A Strategic Shift in National Health Policy Pakistan is taking decisive steps toward self-reliance in healthcare with a renewed focus on local vaccine production. Federal Minister for National Health Services, Mustafa Kamal, has called on the Drug Regulatory Authority of Pakistan (DRAP) and the pharmaceutical industry to…
-
DRAP Urges Local Vaccine Production as GAVI, UNICEF Support Ends by 2031
The Drug Regulatory Authority of Pakistan (DRAP) has urged the country’s pharmaceutical manufacturers to begin local vaccine production, highlighting the urgency of self-reliance as international support winds down. Speaking at a scientific session hosted by the Pakistan Pharmaceutical Manufacturers Association (PPMA) North Zone, DRAP’s newly appointed CEO, Dr. Obaidullah, warned that by 2031, the Global…
-
Drug Regulation in Pakistan: Recent Updates
Drug regulation plays a critical role in ensuring the safety, efficacy, and quality of pharmaceuticals in Pakistan. The regulatory framework, overseen by the Drug Regulatory Authority of Pakistan (DRAP), is vital for protecting public health and maintaining the integrity of the pharmaceutical sector. Recently, significant updates have been made to the Drug Research Rules under…
-
Pakistan Pharma Summit 2024: Industry Leaders Strategize for Pharmaceutical Growth
The 7th Pakistan Pharma Summit, hosted at Islamabad’s Serena Hotel, attracted key industry leaders, government officials, and international experts to discuss the future of Pakistan’s pharmaceutical sector. Mian Khalid Misbah ur Rehman, Chairman of the Pakistan Pharmaceutical Manufacturers Association (PPMA), kicked off the event by highlighting Pakistan’s potential in the global pharmaceutical market. With the…
-
Government Initiates Crackdown on Counterfeit and Contaminated Drugs
ISLAMABAD: The government has launched a major crackdown on counterfeit and Contaminated drugs. The Drug Regulatory Authority of Pakistan (DRAP) has issued a directive to halt the use of products identified as spurious by drug testing laboratories. This notice, released on Friday, applies to healthcare professionals including physicians, pharmacists, nurses, and procurement managers at hospitals…
-
BF Biosciences gets DRAP nod for brownfield expansion
Pakistan’s pharmaceutical company BF Biosciences Limited (BFBL) has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for brownfield expansion. The development was shared by its parent Ferozsons Laboratories Limited in a notice to the Pakistan Stock Exchange (PSX) on Monday. “We are pleased to inform that BF Biosciences Limited, a subsidiary of Ferozsons…